The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? (Q33899616)

29 July 2017

1 reference

title

The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? (English)

1 reference

29 July 2017

0 references

Preiksaitis JK

1

1 reference

29 July 2017

1 April 2000

1 reference

Transfusion Medicine Reviews

29 July 2017

1 reference

29 July 2017

14

1 reference

29 July 2017

2

1 reference

29 July 2017

112-136

1 reference

The role of leukodepletion in the control of transfusion-transmitted disease

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus Infections Associated with Leukocyte Transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Asymptomatic primary cytomegalovirus infection: virologic and immunologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Occupational Risk for Primary Cytomegalovirus Infection among Pediatric Health-Care Workers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Latent cytomegalovirus infection in blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Human cytomegalovirus latent infection of granulocyte-macrophage progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection in a volunteer blood donor population

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Relation of Titers of Antibodies to CMV in Blood Donors to the Transmission of Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Failure to Detect Human Cytomegalovirus DNA in IgM-Seropositive Blood Donors by Spot Hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Posttransfusion cytomegalovirus infection in neonates: role of saline-washed red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Detection of cytomegalovirus in blood donors by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Human cytomegalovirus DNA is not detectable with nested double polymerase chain reaction in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Phenotypic characterization of white cells in white cell-reduced red cell concentrate using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The risk of transmitting cytomegalovirus infection by fresh frozen plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Survival of cytomegalovirus in viremic blood under blood bank storage conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Subclinical cytomegalovirus infections and cytomegalovirus mononculeosis after open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The risk of transmitting cytomegalovirus to patients receiving blood transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion-acquired cytomegalovirus infection in children in a hyperendemic area.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Blood donor selection can prevent cytomegalovirus infection after open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Leucocyte and platelet-derived bioactive substances in stored blood: effect of prestorage leucocyte filtration.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Mononuclear cell microchimerism and the immunomodulatory effect of transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Persistence of donor cells in neonates after fetal and exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Severe cytomegalovirus infection in multiply transfused, splenectomized, trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Association of cytomegalovirus infection with increased morbidity is independent of transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of transfusion-acquired cytomegalovirus infections in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus screened blood for neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Use of Deglycerolized Red Blood Cells to Prevent Posttransfusion Infection with Cytomegalovirus in Neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus Infection in Dialysis Patients and Personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Optimal conditions for white cell reduction in red cells by filtration at the patient's bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Acquisition of donor strains of cytomegalovirus by renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection and reinfection transmitted by heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infections in seropositive patients after transfusion. The effect of red cell storage and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

High incidence of active cytomegalovirus infection among septic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegaloviruria in older infants in intensive care nurseries

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion-acquired cytomegalovirus infection in neonates. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection in a neonatal intensive care unit. Blood transfusion practices and incidence of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The incidence and consequences of cytomegalovirus transmission via blood transfusion to low birth weight, premature infants in north east Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Posttransfusion graft-versus-host disease in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Posttransfusion graft-versus-host disease in Japanese newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion-associated graft-versus-host disease in the neonate-expanding the spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Are guidelines for use of gamma irradiation for the prevention of transfusion-associated graft-versus-host disease adequate for newborns?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Sequelae of maternally derived cytomegalovirus infections in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transmission of cytomegalovirus to preterm infants through breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Current issues in neonatal transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Impact of cytomegalovirus infection on organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infections in heart and heart and lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Surveillance for CMV infection in orthotopic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Donated organ as a source of cytomegalovirus in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Infections in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infections in heart and heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus Infection in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion of the HIV-seropositive patient: immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Transfusion practices in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Identification of Multiple Cytomegalovirus Strains in Homosexual Men with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

The importance of primary cytomegalovirus infection in childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cellular and Humoral Immunity in the Pathogenesis of Recurrent Herpes Viral Infections in Patients with Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegaloviremia in children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Thalassemic patients are at high risk for transfusion-transmitted cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Viral infections in transfusion-dependent patients with beta-thalassemia major: the predominant role of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

[Cytomegalo-virus infections in infants with blood exchange transfusions after birth].

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Acquisition of cytomegalovirus infection in infants following exchange transfusion: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

Cytomegalovirus and blood transfusion in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980003-6

7 January 2021

10.1016/S0887-7963(00)80003-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10782497